Group 1 - The core viewpoint of the article is that Northeast Pharmaceutical (000597.SZ) has seen an increase in institutional investor holdings, reaching a total of 8.13 billion shares, which accounts for 56.98% of the company's total equity as of August 27, 2025 [1] - The number of institutional investors holding shares in Northeast Pharmaceutical has increased to five, with a rise in the institutional holding ratio by 1.37 percentage points compared to the previous quarter [1] - Among public funds, there was one fund, Southern CSI 1000 ETF, that increased its holdings, while another fund, Galaxy Kang Le Stock A, saw a slight decrease in its holdings compared to the previous quarter [1] Group 2 - Foreign investment sentiment shows that one foreign fund, Hong Kong Central Clearing Limited, increased its holdings by 0.21% compared to the previous period [1]
机构风向标 | 东北制药(000597)2025年二季度已披露持仓机构仅5家